Asia-Pacific Medical Transport Boxes Market – Industry Trends and Forecast to 2030

Asia-Pacific Medical Transport Boxes Market Analysis and Size

One of the primary factors driving the growth of the Asia-Pacific medical transport boxes market is the increased incidence of chronic disorders leading to organ transplantation. The continuing clinical trial research being conducted by several companies for better results leads to market expansion. The market is also influenced by the rise in healthcare expenditure and disposable income and easy transportation of fragile and expensive items. However, the poor reimbursement scenario acts as a restraining factor for the Asia-Pacific medical transport boxes market in the forecast period.

On the other hand, the increased incidence of the chronic disorder leading to organ transplantation is driving the market. However, high competition among the market players is restraining the growth of the Asia-Pacific medical transport boxes market in the forecast period.

The demand for medical transport boxes will increase Asia-Pacific due to a rise in product development and awareness regarding its benefits.

Asia-Pacific medical transport boxes market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyses that the Asia-Pacific medical transport boxes market will grow at a CAGR of 6.3% during the forecast period of 2023 to 2030.

MARKET DEFINITION

Medical transport boxes are defined as the boxes that are used for the transport of specimens. They are an essential component in managing product custody through the last mile of the medical cold chain. They are used for the storage of vaccines and dilutens at a prescribed temperature. It offers a temperature-controlled and protected environment for transportation. It provides various transport solutions regarding storage volume and temperature requirements and is specially designed for transportation, and follows the highest safety standards for the end user and patients.

Medical Transport Boxes Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

• Increased Incidence of Chronic Disorder Leads to Organ Transplantation

The increased prevalence of chronic diseases due to the rapidly increasing population and infections can be seen. Individual risk factors, environmental factors, lack of physical activities, and human lifestyles are the major factors that are propelling rising incidences of diseases. The evaluation and replacement of organs will further lead to high demand for clinical studies through different routes of administration in the human body. The number of organ transplant surgeries has increased in recent years for a variety of reasons, including an increase in the number of cases of organ damage from car accidents, such as liver and kidney disease. Along with it, there is an increased occurrence of chronic conditions, including cardiovascular disease and renal failure, which require heart or kidney transplants to improve the health of the human organ system.

These organ needs to be stored in well-maintained and specialized custom medical boxes so that they will be properly stored and can be used for further process.

• Rise in Healthcare Expenditure and Disposable Income

Healthcare expenditure and its growth rate over time are inclined by a wide variety of economic and social factors, including the financing arrangements and structure of the organization of the health system.

Healthcare expenditure has increased across the world as people's disposable income in various countries is increasing. Moreover, to accomplish the population requirements, government bodies and healthcare organizations are taking initiatives by virtue of accelerating healthcare expenditure, and rising use of medical transport box solutions in outpatient care facilities.

Restraints

• Poor Reimbursement Scenario

Reimbursement for all healthcare products has been under downward pressure for several years. These devices also face a major roadblock in their growth due to the lack of reimbursement for these products. The reimbursement of products can significantly affect the ability of a provider to access a particular technology, as well as the willingness of a manufacturer to deliver it. If coverage is uncertain, the manufacturer has difficulty predicting whether an investment in new technology will yield enough returns. This lack of predictability is an apparent barrier to obtaining funding for the company. It further compromises innovation and restricts patient access to advanced technology and solutions.

Medical transport boxes have become an important part of healthcare in terms of the safe transportation of specimens. The increasing application of medical boxes in conditions like cardiovascular disease and renal failure, among more, makes it crucial for the healthcare facility. However, the high cost of such products and the lack of a proper reimbursement policy hampers the adoption rate of these products.

Thus, the poor reimbursement scenarios act as a restraint to the growth of the Asia-Pacific medical transport boxes market.

Opportunity

• Rise In Technological Advancement For Product Development

Growing healthcare infrastructure and the rise in technology help provide better critical care, leading to faster recovery and rehabilitation into normal life. Also, as an investment in healthcare increases, more people are getting aware and desire advanced critical care equipment and diagnosing their health for precaution and cure. This process needs faster transportation of medical equipment, medicines and other consumables.

The increasing rise in technology in product development needs advancement in transportation also helps patients to take hassle-free advanced treatment for better diagnosis, and fast recovery is acting as an opportunity for growing the demand of the market.

An increase in healthcare expenditure leads to the implementation of advanced technologies, equipment & products and better treatment for critical care patients, leading to faster recovery through the transport of medical boxes needed to deliver. For this reason, faster recovery and rehabilitation into a normal life are expected to act as an opportunity for growing the demand for the Asia-Pacific medical transport boxes market.

   Challenge

• Stringent Regulations For Product Approval

The concerns regarding the efficacy and safety of products have caused most governments to develop regulatory agencies and policies to look after the development and transportation of new devices and critical care consumables. The use of medical boxes can be done after passing stringent regulatory standards, which ensure the medical boxes are safe, well-studied, and has no adverse reactions.

The recent guidelines and the amendment have adequate guidance for manufacturers. International regulations such as food, drugs, and administration play a major role in the new launch of the medical boxes transportation into the market. Thus, it is expected to be a major market challenge.

Some special controls also include implementing post-marketing surveillance measures, guidance documents, adherence to performance standards, and special labeling.

Thus, stringent government regulations on medical box transportation approval are expected to impact the growth of the Asia-Pacific medical transport boxes market.

Post COVID-19 Impact on Asia-Pacific Medical Transport Boxes Market

Previously, routine care, as well as emergency care, crisis care, and other types of care, making use of remote care and telemedical transport boxes services. Their use in a more widespread capacity has picked up speed as the COVID-19 pandemic has progressed. Telemedical transport boxes services are now being used in the large-scale screening of patients prior to their visit and triage assessment, in the routine monitoring of patients at home, for remote clinical encounters, or for supervising patient care by off-site experts. Telemedical transport box services are also being used in the United Kingdom to screen patients at home. It is likely that a significant portion of such services will continue to be based on telemedical transport boxes after COVID-19, for example, the remote monitoring and management of a greater number of patients. This is because telemedical transport boxes offer greater convenience and better patient-centered care, which helps to partially address the challenges of the flow rate and capacity within the healthcare system.

This phenomenon has also been observed in the field of mental healthcare, where the pandemic acted as a catalyst for the implementation of online therapy and e-health tools in routine practice. This came after more than two decades of many brilliant but mostly unsuccessful attempts to improve mental healthcare. The imperatives that have dominated the field, such as the belief that "the clinician/patient therapeutic alliance can only be established face-to-face," despite research showing the opposite, are being resolved. One example of this is the belief that "the clinician/patient therapeutic alliance can only be established face-to-face." It is possible that once mental healthcare institutions have developed the capabilities post-COVID-19 of serving their patients via various digital technologies, there will be little reason for them to give all of these up in light of the benefits they have experienced over an extended period of crisis response. This is because of the fact that COVID-19 was passed after mental healthcare institutions had already developed these capabilities. It is likely that in the not-too-distant future, a "blended approach" will emerge, in which e-mental-health solutions will take up a greater proportion of routine services. In addition, the knowledge and skills that are currently being developed can be put to use in the development of a more comprehensive public e-mental health approach. This would involve the utilization of interventions that are not only guided but also fully self-guided, such as self-help apps or online therapeutic modules. As a positive post-COVID-19 long-term outcome, the latter could also be tested and eventually applied in settings and countries with scarce mental health resources where such a need has been previously identified.

Recent Development

• In October 2021, the Innova Medical Group inaugurated its first rapid antigen test production line in France, in Pithiviers, Loiret. The company believes this will help in its business expansion and in the economic development of the Centre-Val de Loire region.
• In December 2022, Focus Technology Co., Ltd. launched Aucma China's big-capacity low-temperature equipment blood bank refrigerator for cryopreservation purposes.

Asia-Pacific Medical Transport Boxes Market Scope

The Asia-Pacific medical transport boxes market is categorized into six notable segments based on product type, material, application, design, end user, and distribution channel.

By Product Type

• Traditional Medical Boxes
• Cold-Storage Medical Boxes

On the basis of product type, the Asia-Pacific medical transport boxes market is further segmented into traditional medical boxes and cold storage medical boxes.

By Material

• Plastic
• Corrugated Boxes
• Metal

On the basis of material, the Asia-Pacific medical transport boxes market is segmented into plastic, corrugated boxes, and metal.

Application       

• Medicines
• Test Specimen 
• Vaccines
• Blood
• Organ
• Medical Devices
• Medical Waste
• Others

On the basis of application, the Asia-Pacific medical transport boxes market is segmented into medicines, test specimens, vaccines, blood, organ, medical devices, medical waste, and others.

By Design

• Regular Boxes
• Custom Boxes

On the basis of design, the Asia-Pacific medical transport boxes market is segmented into regular boxes and custom boxes.

End User

• Diagnostic Laboratories
• Blood Banks
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Academic and Research Institutes
• Others

On the basis of end user, the Asia-Pacific medical transport boxes market is segmented into diagnostic laboratories, blood banks, hospitals, clinics, ambulatory surgical centers, academic, research institutes, and others.

Distribution Channel

• Direct Tender
• Retail Sales
• Others

On the basis of distribution channel, the Asia-Pacific medical transport boxes market is segmented into direct tender, retail sales, and others.

Medical Transport Boxes Market Regional Analysis/Insights

The Asia-Pacific medical transport boxes market is analyzed, and market size insights and trends are provided by product type, material, application, design, end user, and distribution channel as referenced above.

The countries covered in the medical transport boxes report China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific.

Asia-Pacific is dominating the medical transport boxes market. The broad base of the medical transport boxes industry in the country, with significant spending in healthcare, is set to drive the market growth for various devices and equipment used to deliver to different end users of the medical transport boxes market. The China dominates the Asia-Pacific region due to the exponential use of remote monitoring and transport boxes.

The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Medical Transport Boxes Market Share Analysis

Asia-Pacific medical transport boxes market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the medical transport boxes market.

Some of the key players operating in the Asia-Pacific medical transport boxes market are The Yebo Group, Shuttlepac Ltd, Summit Medical LLC, B medical systems, BWAY Corporation, Avantor, Inc., Sonoco Products Company, Orlando Products Inc., TRANSPAK, INC., Star Industrial, Thermo Fisher Scientific, and SARSTEDT AG & Co. KG, among others.

SKU-69781